Media formats available:
Recommended
- The Imminent danger of Lp(a): Time to face to challengePhase II data on Lp(a) lowering, followed by NHLBI recommendation
Prof. Sam Tsimikas
- The Imminent danger of Lp(a): Time to face to challengeLp(a) apheresis and CVD risk modulation
Elisa Waldmann, MD
- The Imminent danger of Lp(a): Time to face to challengePrevalence and relevance of elevated Lp(a) in familial hypercholesterolemia
Prof. Børge Nordestgaard, MD
- The Imminent danger of Lp(a): Time to face to challengeAre we ready for prime-time Lp(a) assay standardization?
Prof. Santica Marcovina